Anzeige
Mehr »
Freitag, 10.04.2026 - Börsentäglich über 12.000 News
Research Capital bestätigt $3,00 Kursziel - FUTR zündet die nächste Stufe: Vom Fintech zur globalen Finanzplattform
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0N99U | ISIN: CNE100000FN7 | Ticker-Symbol: X2S
Stuttgart
09.04.26 | 21:55
2,280 Euro
0,00 % 0,000
Branche
Pharma
Aktienmarkt
HANG SENG
1-Jahres-Chart
SINOPHARM GROUP CO LTD Chart 1 Jahr
5-Tage-Chart
SINOPHARM GROUP CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
2,2822,30409.04.
2,2772,32209.04.

Aktuelle News zur SINOPHARM Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
01.04.SINOPHARM (01099): ANNOUNCEMENT PRINCIPAL AUDITED ACCOUNTING DATA AND FINANCIAL INDICATORS OF SINOPHARM ACCORD FOR THE YEAR ENDED 31 DECEMBER 20256
24.03.Citi Keeps Buy on SINOPHARM but Slashes TP to HKD22.819
23.03.Sinopharm Group Co. Ltd. Bottom Line Rises In Full Year11
23.03.SINOPHARM Annual NP Grows 1.5% to RMB7.155B; Final Div. RMB0.698
20.03.Reed Sinopharm Exhibitions (RSE): PCHi 2026: World's Largest Cosmetics Ingredients Exhibition Opens in Hangzhou1.029860+ exhibitors from 26 countries and regions across 70,000 sqmClose to 50 new product launches, including global and China debuts295 product submissions and 19 engineer nominations for the...
► Artikel lesen
19.03.Woori IO signs NDA with Sinopharm for glucose monitoring tech2
19.03.SINOPHARM (01099): ANNOUNCEMENT PRINCIPAL ACCOUNTING DATA AND FINANCIAL INDICATORS OF SINOPHARM (CNCM LTD) FOR THE YEAR ENDED 31 DECEMBER 20254
19.03.SINOPHARM (01099): ANNOUNCEMENT PRINCIPAL FINANCIAL DATA OF CNMDC FOR THE YEAR ENDED 31 DECEMBER 20255
SINOPHARM Aktie jetzt für 0€ handeln
19.03.OSR Holdings, Inc.: Woori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial Opportunities482BELLEVUE, WA / ACCESS Newswire / March 19, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH), a healthcare-focused holding company advancing innovative medical technologies, today announced that its subsidiary...
► Artikel lesen
17.03.SINOPHARM (01099): ANNOUNCEMENT PRELIMINARY FINANCIAL DATA OF SINOPHARM ACCORD FOR THE YEAR OF 202514
10.03.SINOPHARM (01099): NOTICE OF BOARD MEETING7
19.12.25SINOPHARM (01099): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION7
19.12.25SINOPHARM (01099): ANNOUNCEMENT POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON FRIDAY, 19 DECEMBER 20254
03.12.25SINOPHARM (01099): FORM OF PROXY FOR EXTRAORDINARY GENERAL MEETING TO BE HELD ON FRIDAY, 19 DECEMBER 20254
03.12.25SINOPHARM (01099): NOTICE OF EXTRAORDINARY GENERAL MEETING3
03.12.25SINOPHARM (01099): (1) PROPOSED APPOINTMENT OF NON-EXECUTIVE DIRECTORS; (2) PROPOSED APPOINTMENT OF EXECUTIVE DIRECTOR; AND (3) NOTICE OF EGM3
28.11.25SINOPHARM (01099): ANNOUNCEMENT (1) PROPOSED CHANGE OF NON-EXECUTIVE DIRECTORS, THE CHAIRMAN AND THE AUTHORIZED REPRESENTATIVE; (2) CHANGE IN COMPOSITION ...1
06.11.25SINOPHARM (01099): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION1
06.11.25SINOPHARM (01099): ANNOUNCEMENT PROPOSED CHANGE OF EXECUTIVE DIRECTOR2
30.10.25SINOPHARM (01099): ANNOUNCEMENT PRINCIPAL UNAUDITED ACCOUNTING DATA AND FINANCIAL INDICATORS OF SINOPHARM ACCORD FOR THE THIRD QUARTER OF 20254
Weiter >>
37 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1